Resource Center
Emmes possesses deep experience in clinical research which we leverage on behalf of our clients. It is through our collaborative efforts with you that Emmes has conducted over 2,150 clinical trials and published 2,300+ peer-reviewed articles.
In this section of our site, we share our experience and publications with you as a tribute to our ongoing collaboration.
Resources
Publications
Effect of the oral protein kinase C b Inhibitor, Ruboxistaurin, on visual acuity in the PKC-DRS2 Study
2006
Vignati, L., Sheetz, M.J., Girach, A., Zhi, X., Davis, M.D., Milton, R.C., Group, Afor the P.K.
Effect of the orally administered PKC b Inhibitor, Ruboxistaurin, on sustained moderate visual loss in the PKC-DRS2 Study
2006
Brucker, A., Aiello, L.P., Vignati, L., Sheetz, M.J., Zhi, X., Girach, A., Davis, M.D., Group, R.C.Milton for
Effect of the Orally Administered PKC b Inhibitor, Ruboxistaurin, on Visual Acuity in the PKC-DRS2 Study
2006
Aiello, L.P., Vignati, L., Sheetz, M.J., Zhi, X., Girach, A., Davis, M.D., Group, R.C.Milton for
Effects of Long-term Zinc Supplementation on Plasma Thiol Metabolites and Redox Status in Patients With Age-Related Macular Degeneration
02/2007
Moriarty-Craig, S., Ha, K., Sternberg, P., Lynn, M., Bressler, S., Gensler, G., Jones, D.
Intravitreal Anti-Vascular Endothelial Growth Factor Therapy with Pegaptanib for Advanced Von Hippel-Lindau Disease of the Retina
02/2007
Dahr, S., Cusic, M., Rodriguez-Coleman, H., Srivastava, S., Thompson, D., Ferris, F., Csaky, K., Linehan, M., Chew, E.
Safety, Immunogenicity and Efficacy of Modified Vaccinia Ankara (MVA) Against Dryvax Challenge in Vaccinia-Naive and Vaccinia-Immune Individuals
02/2007
Parrino, J., McCurdy, L.H., Larkin, B.D., Gordon, I.J., Rucker, S.E., Enama, M.E., Koup, R.A., Roederer, M., Bailer, R.T., Moodie, Z., Gu, L., Yan, L., Graham, B.S., Team, T.V.R.C. 201/20
Second Annual Analysis of the Collaborative Islet Transplant Registry
01-02/2007
Close, N., Alejandro, R., Hering, B., Appel, M., Investigators, T.Collaborat
Studies of a Prophylactic HIV-1 Vaccine Candidate Based on Modified Vaccinia Virus Ankara (MVA) with and without DNA Priming: Effects of Dosage and Route on Safety and Immunogenicity
03/2007
Peters, B.S., Jaoko, W., Vardas, E., Panayotakopoulos, G., Fast, P., Schmidt, C., Gilmour, J., Bogoshi, M., Manyonyi, O., Dally, L., Klavinskis, L., Farah, B., Tarragona, T., Bart, P.A., Robinson, A., Pieterse, C., Stevens, W., Thomas, R., Barin, B., Bwayo, J.[...]
Younger Age and Antibody Induction Increase the Risk for Infection in Pediatric Renal Transplantation: A NAPRTCS Report
03/2007
Puliyanda, D., Stablein, D., Dharnidharka, V.